A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care

NCT02279004 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
840
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Dana-Farber Cancer Institute

Collaborators